Integrated gut microbiome and metabolomics analysis reveals microbial-metabolic cross-talk in allergic rhinitis
Frontiers in Microbiology · 12.11.2025 · 16
DOI: 10.3389/fmicb.2025.1652915 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 12.11.2025. Verfasst von Guangchen Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Liaoning Province.
Abstract (Originalsprache)
Background
Emerging evidence indicates a link between gut dysbiosis and allergic rhinitis (AR) pathogenesis. Nevertheless, the mechanistic role of gut microbiota in AR progression requires further characterization. To address this, we employed an integrated multi-omics strategy to delineate gut microbial composition and metabolic signatures in AR patients.
Methods
Fecal specimens from 23 AR patients and 15 matched healthy controls (total n = 38) were subjected to 16S rRNA gene sequencing to assess bacterial community structure, alongside untargeted metabolomic profiling of microbial metabolites. Spearman’s rank correlation analysis was applied to evaluate microbiota-metabolite interactions.
Results
Allergic rhinitis patients exhibited altered gut microbial community structure (beta diversity, P < 0.05) with depletion of SCFA-producing genera such as Faecalibacterium and enrichment of pro-inflammatory taxa like Fusobacterium . Metabolomic profiling identified significant disturbances in pathways including pantothenate and CoA biosynthesis, glycolysis, and pyruvate metabolism. Key discriminatory metabolites included maltol and 4-coumaric acid. Integrative analysis revealed significant correlations between specific bacteria and metabolites, such as Faecalibacterium with D-phenyllactic acid (ρ = 0.515, q = 0.046).
Conclusion
Our findings demonstrate that AR is associated with gut dysbiosis and metabolic dysfunction, highlighting the role of microbial-derived metabolites in immune regulation via the gut-nose axis. These insights support the potential for microbiota-targeted therapeutic strategies in AR management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
- College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, China.
- Department of Respiratory Medicine, The 962nd Hospital of the PLA Joint Logistic Support Force, Harbin, Heilongjiang, China.
Förderung
- Natural Science Foundation of Liaoning Province
Zitieren
APA
Sun, G., Zhao, S., Huang, H., Guan, W., Wang, X., Zhang, H., Zhang, M., Hou, D., Xu, C., & Chai, R. (2025). Integrated gut microbiome and metabolomics analysis reveals microbial-metabolic cross-talk in allergic rhinitis. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1652915
Vancouver
Sun G, Zhao S, Huang H, Guan W, Wang X, Zhang H, et al. Integrated gut microbiome and metabolomics analysis reveals microbial-metabolic cross-talk in allergic rhinitis. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1652915
BibTeX
@article{Sun2025,
author = {Sun, Guangchen and Zhao, Shouyan and Huang, Hehua and Guan, Wenchao and Wang, Xinzhuo and Zhang, Hong and Zhang, Min and Hou, Denghan and Xu, Chong and Chai, Ruonan},
title = {Integrated gut microbiome and metabolomics analysis reveals microbial-metabolic cross-talk in allergic rhinitis},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1652915}
}
EUVIMED